Assistant professor of Division of Transfusion Medicine and Hemophilia Treatment CenterHiroshima University HospitalHiroshima, Hiroshima, Japan
PB0535 - How much is the coagulation ability of emicizumab in hemophilia A patients treated with it, when converted to factor VIII activity?
Monday, June 24, 202413:45 – 14:45 ICT
